TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/20/21 18:59 | 4/16/21 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Loven Jakob | CA | D | S.m | -1,418 | 20.64 | 0 | -69 | -5 | 1,302 | I | |||||||||||||||
4/15/21 18:57 | 4/13/21 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Loven Jakob | CA | D | S.m | -1,690 | 22.70 | 0 | -74 | -5 | 1,370 | I | |||||||||||||||
4/12/21 20:33 | 4/8/21 | KRON | Kronos Bio, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Loven Jakob | CA | D | S.m | -2,736 | 27.19 | 0 | -101 | -7 | 1,445 | I | |||||||||||||||
10/3/18 17:18 | 10/1/18 | ARVN | Arvinas Inc. | DE | Health | Drug | Pharmaceutical Preparations | Loven Jakob | CT | D | P.d | 5,000 | 16.00 | 0 | 313 | 23 | 1,694 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |